The role of the pharmacist in hypertension management

Current Opinion in Cardiology

Volumn 33, Issue 4, 2018, Pages 382-387

  Di Palo, Katherine E ^a   Kish, Troy ^b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b LONG ISLAND UNIVERSITY   (United States)

Author keywords

collaborative drug therapy management; hypertension; pharmacist; team based care; telehealth

Indexed keywords

AMBULATORY CARE; CLINICAL EVALUATION; CLINICAL PRACTICE; COMMUNITY CARE; EARLY INTERVENTION; HEALTH CARE DELIVERY; HUMAN; HYPERTENSION; MANAGED CARE; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; META ANALYSIS (TOPIC); MORTALITY RATE; PATIENT COUNSELING; PHARMACEUTICAL CARE; PHARMACIST ATTITUDE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); TEAMWORK; TELEHEALTH; TREATMENT OUTCOME; DISEASE MANAGEMENT; PATIENT CARE; PHARMACIST; TELEMEDICINE;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; DISEASE MANAGEMENT; HUMANS; HYPERTENSION; PATIENT-CENTERED CARE; PHARMACISTS; TELEMEDICINE;

EID: 85050403419     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0000000000000527     Document Type: Review

References (51)

1. Bakris G, Sorrentino M. Redefining hypertension-Assessing the new bloodpressure guidelines. N Engl J Med 2018; 378:497-499.
2. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017; 24430.
3. Merai R, Siegel C, Rakotz M, et al. CDC grand rounds: A public health approach to detect and control hypertension. MMWR Morb Mortal Wkly Rep 2016; 65:1261-1264.
4. Drazner MH. The progression of hypertensive heart disease. Circulation 2011; 123:327-334.
5. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382:260-272.
6. Brunner HR, Laragh JH, Baer L, et al. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 1972; 286:441-449.
7. Chabot I, Moisan J, Grégoire J-P, Milot A. Pharmacist intervention program for control of hypertension. Ann Pharmacother 2003; 37:1186-1193.
8. Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother 2005; 39:1828-1832.
9. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: A key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004; 19:357-362.
10. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002; 288:2880-2883.
11. Burke JM, Miller WA, Spencer AP, et al. Clinical pharmacist competencies. Pharmacotherapy 2008; 28:806-815.
12. Murphy JE, Nappi JM, Bosso JA, et al. American College of Clinical Pharmacys vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice. Pharmacotherapy 2006; 26:722-733.
13. Mechanic D, McAlpine DD, Rosenthal M. Are patients office visits with physicians getting shorter? N Engl J Med 2001; 344:198-204.
14. Tai-Seale M, McGuire TG, Zhang W. Time allocation in primary care office visits. Health Serv Res 2007; 42:1871-1894.
15. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc 2000; 40:157-165.
16. Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy 2002; 22:1533-1540.
17. Brown CA, Bailey JH, Rudman WJ, et al. The pharmacist-physician relationship in the detection of ambulatory medication errors. Am J Med Sci 2006; 331:22-24.
18. Di Blasi Z, Harkness E, Ernst E, et al. Influence of context effects on health outcomes: A systematic review. Lancet 2001; 357:757-762.
19. Hojat M, Louis DZ, Markham FW, et al. Physicians empathy and clinical outcomes for diabetic patients. Acad Med 2011; 86:359-364.
20. Riley R, Weiss MC, Platt J, et al. A comparison of GP, pharmacist and nurse prescriber responses to patients emotional cues and concerns in primary care consultations. Patient Educ Couns 2013; 91:65-71.
21. Taitel M, Jiang J, Rudkin K, et al. The impact of pharmacist face-To-face counseling to improve medication adherence among patients initiating statin therapy. Patient Prefer Adherence 2012; 6:323.
22. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-Term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003; 43:173-184.
23. Mc Namara KP, Versace VL, Marriott JL, Dunbar JA. Patient engagement strategies used for hypertension and their influence on self-management attributes. Fam Pract 2014; 31:437-444.
24. Anderegg MD, Gums TH, Uribe L, et al. Physician-pharmacist collaborative management: narrowing the socioeconomic blood pressure gap. Hypertension 2016; 68:1314-1320.
25. Dixon DL, Sisson EM, Parod ED, et al. Pharmacist-physician collaborative care model and time to goal blood pressure in the uninsured population. J Clin Hypertens 2018; 20:88-95.
26. Wiysonge CS, Bradley HA, Volmink J, Mayosi BM. Cochrane corner: betablockers for hypertension. Heart 2018; 104:282-283.
27. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: A review of literature. J Behav Med 2008; 31:213-224.
28. Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC. Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care 2009; 15:e22-e33.
29. Anderegg MD, Gums TH, Uribe L, et al. Pharmacist intervention for blood pressure control in patients with diabetes and/or chronic kidney disease. Pharmacotherapy 2018; 38:309-318.
30. Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc 2005; 45:566-572.
31. Barnett M, Frank J, Wehring H, et al. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm 2009; 15:18-31.
32. Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacists-2003. Pharmacotherapy 2003; 23: 1210-1225.
33. McBane SE, Dopp AL, Abe A, et al. Collaborative drug therapy management and comprehensive medication management-2015. Pharmacotherapy 2015; 35:e39-e50.
34. McKnight AG, Thomason AR. Pharmacists advancing roles in drug and disease management: A review of states legislation. J Am Pharm Assoc 2009; 49:554-558.
35. Greer N, Bolduc J, Geurkink E, et al. Pharmacist-led chronic disease management: A systematic review of effectiveness and harms compared with usual care. Ann Intern Med 2016; 165:30-40.
36. Kislan MM, Bernstein AT, Fearrington LR, Ives TJ. Advanced Practice Pharmacists: A retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC). BMC Health Serv Res 2016; 16:607.
37. Tsuyuki RT, Al Hamarneh YN, Jones CA, Hemmelgarn BR. The effectiveness of pharmacist interventions on cardiovascular risk: The multicenter randomized controlled RxEACH trial. J Am Coll Cardiol 2016; 67:2846-2854.
38. Fortuna RJ, Nagel AK, Rose E, et al. Effectiveness of a multidisciplinary intervention to improve hypertension control in an urban underserved practice. J Am Soc Hypertens 2015; 9:966-974.
39. Mills KT, Obst KM, Shen W, et al. Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: A systematic review and meta-Analysis. Ann Intern Med 2018; 168:110-120.
40. Smith SM, Hasan M, Huebschmann AG, et al. Physician acceptance of a physician-pharmacist collaborative treatment model for hypertension management in primary care. J Clin Hypertens 2015; 17:686-691.
41. Carter BL. Primary care physician-pharmacist collaborative care model: strategies for implementation. Pharmacotherapy 2016; 36:363-373.
42. Hedegaard U, Kjeldsen LJ, Pottega° rd A, et al. Multifaceted intervention including motivational interviewing to support medication adherence after stroke/transient ischemic attack: A randomized trial. Cerebrovasc Dis Extra 2014; 4:221-234.
43. Hedegaard U, Kjeldsen LJ, Pottega° rd A, et al. Improving medication adherence in patients with hypertension: A randomized trial. Am J Med 2015; 128:1351-1361.
44. Fikri-Benbrahim N, Faus MJ, Martínez-Martínez F, Sabater-Hernández D. Impact of a community pharmacists hypertension-care service on medication adherence. The AFenPA study. Res Social Adm Pharm 2013; 9:797-805.
45. Gums TH, Uribe L, Vander Weg MW, et al. Pharmacist intervention for blood pressure control: medication intensification and adherence. J Am Soc Hypertens 2015; 9:569-578.
46. Krousel-Wood M, Hyre A, Muntner P, Morisky D. Methods to improve medication adherence in patients with hypertension: current status and future directions. Curr Opin Cardiol 2005; 20:296-300.
47. Abughosh S, Wang X, Serna O, et al. A motivational interviewing intervention by pharmacy students to improve medication adherence. J Manag Care Spec Pharm 2017; 23:549-560.
48. Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: A cluster randomized clinical trial. JAMA 2013; 310:46-56.
49. Choudhry NK LJ, Gopalakrishnan C, et al. Results of the study of a telepharmacy intervention for chronic diseases to improve treatment adherence (STIC2IT). Presented at the 2017 American Heart Association Scientific Sessions, Anaheim, California; November 11-15, 2017. LS-6.
50. Asche SE, OConnor PJ, Dehmer SP, et al. Patient characteristics associated with greater blood pressure control in a randomized trial of home blood pressure telemonitoring and pharmacist management. J Am Soc Hypertens 2016; 10:873-880.
51. Milani RV, Lavie CJ, Bober RM, et al. Improving hypertension control and patient engagement using digital tools. Am J Med 2017; 130:14-20. Dual intervention of pharmacist counseling and telehealth tools to achieve BP control.